Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Safety Evaluation of Escalating Doses”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT02431364
What this trial is testing

Trial of Safety and Tolerability of Oral Verdinexor (KPT-335) in Healthy Adults

Who this might be right for
Healthy
Karyopharm Therapeutics Inc 33
Early research (Phase 1)Study completedNCT02020291
What this trial is testing

Phase I Study to Evaluate Safety, Tolerability, Anti-Tumour Activity and PK Profiles of Foxy-5 in Metastatic Breast, Colon or Prostate Cancer

Who this might be right for
Metastatic Breast CancerColorectal CancerProstate Cancer
WntResearch AB 31
Early research (Phase 1)Study completedNCT01990846
What this trial is testing

Safety, Tolerability, and PK of Escalating Doses of Flufirvitide-3 Dry Powder for Inhalation in Healthy Subjects

Who this might be right for
Influenza
Autoimmune Technologies, LLC 68
Early research (Phase 1)Study completedNCT02065973
What this trial is testing

An Open-Label, Phase I, Escalating Dose Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of PDS0101

Who this might be right for
High-risk HPV Infection and Biopsy-proven CIN1
PDS Biotechnology Corp. 12
Early research (Phase 1)Study completedNCT01585857
What this trial is testing

ADIPOA - Clinical Study

Who this might be right for
Osteoarthritis
University Hospital, Montpellier 18
Early research (Phase 1)Study completedNCT05490017
What this trial is testing

To Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Escalating Single and Multiple Doses of KP104

Who this might be right for
Paroxysmal Nocturnal Hemoglobinuria
Kira Pharmacenticals (US), LLC. 80
Early research (Phase 1)Study completedNCT01740609
What this trial is testing

Assess The Safety Of PF-06342674 In Healthy Volunteers

Who this might be right for
Healthy
Pfizer 80
Early research (Phase 1)Study completedNCT01093911
What this trial is testing

Safety Study of CDP7657 in Healthy Volunteers and Patients With Systemic Lupus Erythematosus (SLE)

Who this might be right for
Immune System DiseasesAutoimmune DiseasesLupus Erythematosus, Systemic+2 more
UCB Pharma 44
Testing effectiveness (Phase 2)Study completedNCT03482050
What this trial is testing

Evaluate Transplantation of Astrocytes Derived From Human Embryonic Stem Cells, in Patients With Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
ALS (Amyotrophic Lateral Sclerosis)
Kadimastem 16
Early research (Phase 1)Ended earlyNCT01238679
What this trial is testing

Study to Evaluate the Safety, Tolerability and Pharmacokinetics of PF-04958242 in Healthy Adult Volunteers

Who this might be right for
Healthy Volunteers
Biogen 20
Early research (Phase 1)Study completedNCT00486382
What this trial is testing

Open-Label Safety Study of Three-Antigen Leishmania Polyprotein With Adjuvant MPL-SE in Healthy Adults in India

Who this might be right for
Visceral LeishmaniasisPost-kala-azar Dermal Leishmaniasis
Access to Advanced Health Institute (AAHI) 36
Testing effectiveness (Phase 2)Study completedNCT01483924
What this trial is testing

Study to Evaluate Apo805K1 in Subjects With Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
ApoPharma 60
Early research (Phase 1)Looking for participantsNCT07473323
What this trial is testing

Evaluation of MTX-439 in Healthy Adults and Adults With Diabetic Kidney Disease

Who this might be right for
Healthy Adult ParticipantsDiabetic Kidney Disease
Mediar Therapeutics 88
Early research (Phase 1)Study completedNCT00808119
What this trial is testing

Safety, Tolerability, and Pharmacokinetics of Single, Escalating Oral Doses of RTI-336 in Healthy, Male Subjects

Who this might be right for
Cocaine Dependence
RTI International 30
Testing effectiveness (Phase 2)Study completedNCT02737722
What this trial is testing

Topically Applied Bisphosphocin Nu-3 on Infected Diabetic Ulcers of Subjects With Type I or II Diabetes Mellitus

Who this might be right for
Diabetic Foot Infections
Lakewood-Amedex Inc 31
Testing effectiveness (Phase 2)Study completedNCT00966238
What this trial is testing

Safety and Immunogenicity of VAX125 Influenza Vaccine in Community-living Adults >= 65 Years of Age

Who this might be right for
Influenza
VaxInnate Corporation 120
Testing effectiveness (Phase 2)Looking for participantsNCT06937203
What this trial is testing

A First-In-Human Study of ARO-ALK7 in Adults With Obesity With and Without Type 2 Diabetes Mellitus

Who this might be right for
ObesityDiabetes Mellitus, Type 2
Arrowhead Pharmaceuticals 150
Early research (Phase 1)Study completedNCT04857437
What this trial is testing

Study in Healthy Adults Evaluating PF-07202954

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseLiver Fibrosis
Pfizer 12
Early research (Phase 1)Ended earlyNCT05019105
What this trial is testing

Phase 1 ALKS 1140 in Healthy Adults

Who this might be right for
Central Nervous System Diseases
Alkermes, Inc. 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT01797055
What this trial is testing

Apotransferrin in Atransferrinemia

Who this might be right for
Congenital Atransferrinemia
Prothya Biosolutions 5
Next Page